Denny Heck sold Medtronic PLC (NYSE: MDT)
Denny Heck (D-WA), a U.S. Representative, has disclosed 1 trade in Medtronic PLC (MDT) since 2018, a single sale, worth an estimated $33K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Denny Heck sold $15,001 - $50,000 of Medtronic PLC (NYSE: MDT) on March 27, 2018. Since that trade, MDT is up +32.21% against the S&P 500 up +226.24%, an outperformance of -194.03%.
Data updated
Denny Heck's MDT trades vs the price
MDT is up +32.21% since Denny Heck sold on March 27, 2018, versus +226.24% for the S&P 500.
Performance since this trade
All Denny Heck MDT trades
Denny Heck & MDT trading FAQ
Is it legal for Denny Heck to trade Medtronic PLC (MDT) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Medtronic PLC (MDT), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. BullishWhales tracks those disclosures; this page does not imply the trade was improper.
When did Denny Heck sell MDT?
Denny Heck disclosed a sale of $15,001 - $50,000 of Medtronic PLC (MDT) on March 27, 2018, according to public STOCK Act filings.
How has MDT performed since Denny Heck's trade?
Since Denny Heck sold MDT on March 27, 2018, the stock is up +32.21%, versus +226.24% for the S&P 500 over the same period, an outperformance of -194.03%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional MDT trades?
BullishWhales tracks every disclosed congressional trade in Medtronic PLC (MDT) on the Medtronic PLC congressional trading page, which aggregates filings across all members of Congress.
Denny Heck's MDT tradesAll congressional filings for Medtronic PLCDenny Heck's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.